A. Broder

发表

Inhibition of the TWEAK/Fn14 pathway attenuates renal disease in nephrotoxic serum nephritis.

C. Putterman, L. Burkly, Ping Wu, 2012, Clinical immunology.

Outcomes of ST‐elevation myocardial infarction by age and sex in a low‐income urban community: The Montefiore STEMI Registry

J. Kizer, A. Bortnick, R. Faillace, 2020, Clinical cardiology.

Systemic lupus Erythematosus activity and Hydroxychloroquine use before and after end-stage renal disease

B. Goilav, W. Mowrey, M. Salgado Guerrero, 2020, BMC Nephrology.

The association between ABO blood types and venous thromboembolism in individuals with a positive antiphospholipid profile is varied by sex

W. Mowrey, A. Broder, M. Shusterman, 2018, Lupus.

Validation of Systemic Lupus Erythematosus Diagnosis as the Primary Cause of Renal Failure in the US Renal Data System

P. Izmirly, W. Mowrey, K. Costenbader, 2017, Arthritis care & research.

Association between antiphospholipid antibodies and all-cause mortality among end-stage renal disease patients with and without SLE: a retrospective cohort study.

C. Putterman, H. Billett, J. Neugarten, 2016, Rheumatology.

Hydroxychloroquine Use Is Associated with Lower Odds of Persistently Positive Antiphospholipid Antibodies and/or Lupus Anticoagulant in Systemic Lupus Erythematosus

C. Putterman, A. Broder, 2013, The Journal of Rheumatology.

Undertreatment of Disease Activity in Systemic Lupus Erythematosus Patients with Endstage Renal Failure Is Associated with Increased All-cause Mortality

C. Putterman, A. Broder, S. Khattri, 2011, The Journal of Rheumatology.

High antiphospholipid antibody levels are associated with statin use and may reflect chronic endothelial damage in non-autoimmune thrombosis: cross-sectional study

J. Tobin, C. Putterman, A. Broder, 2012, Journal of Clinical Pathology.

Membrane attack complex (MAC) deposition in renal tubules is associated with interstitial fibrosis and tubular atrophy: a pilot study

L. Chiriboga, C. Putterman, H. Belmont, 2022, Lupus Science & Medicine.

Improving Outcomes in Patients with Lupus and End‐Stage Renal Disease

C. Putterman, J. Neugarten, A. Broder, 2013, Seminars in dialysis.

Methodological considerations in comparing access to Pre-emptive renal transplantation between SLE and other ESRD causes in the USRDS.

Mimi Y. Kim, C. Putterman, W. Mowrey, 2019, Seminars in arthritis and rheumatism.

A Comparison of the Malignancy Incidence Among Patients With Psoriatic Arthritis and Patients With Rheumatoid Arthritis in a Large US Cohort

A. Gottlieb, J. Kremer, C. Putterman, 2014, Arthritis & rheumatology.

Systemic lupus Erythematosus activity and Hydroxychloroquine use before and after end-stage renal disease

B. Goilav, W. Mowrey, Shudan Wang, 2020, BMC Nephrology.

Sex Differences in Health Care Utilization, End‐Stage Renal Disease, and Mortality Among Medicaid Beneficiaries With Incident Lupus Nephritis

J. Yazdany, K. Costenbader, C. Feldman, 2018, Arthritis & rheumatology.

AB0397 Pulmonary Hypertension in Rheumatoid Arthritis is Associated with Severe Left Ventricular Diastolic Dysfunction

T. Sheth, A. Broder, 2015 .

Short- and Long-Term Progression of Kidney Involvement in Systemic Lupus Erythematosus Patients with Low-Grade Proteinuria

B. Rovin, M. Petri, J. Buyon, 2022, Clinical journal of the American Society of Nephrology : CJASN.

The constant region contributes to the antigenic specificity and renal pathogenicity of murine anti-DNA antibodies.

A. Casadevall, C. Putterman, Quanzhen Li, 2012, Journal of autoimmunity.

Active peripheral inflammation is associated with pro-atherogenic lipid profile in psoriatic arthritis.

W. Mowrey, A. Broder, A. Shrestha, 2016, Seminars in arthritis and rheumatism.

Dendritic cells: an important link between antiphospholipid antibodies, endothelial dysfunction, and atherosclerosis in autoimmune and non-autoimmune diseases.

C. Putterman, A. Broder, Jimmy J Chan, 2013, Clinical immunology.

Disease-specific definitions of vitamin D deficiency need to be established in autoimmune and non-autoimmune chronic diseases: a retrospective comparison of three chronic diseases

J. Tobin, C. Putterman, A. Broder, 2010, Arthritis Research & Therapy.

Higher Rates and Clustering of Abnormal Lipids, Obesity, and Diabetes Mellitus in Psoriatic Arthritis Compared With Rheumatoid Arthritis

J. Kremer, C. Putterman, J. Greenberg, 2014, Arthritis care & research.

Tubulointerstitial damage predicts end stage renal disease in lupus nephritis with preserved to moderately impaired renal function: A retrospective cohort study.

C. Putterman, P. Izmirly, W. Mowrey, 2018, Seminars in arthritis and rheumatism.

Implementing an Electronic Medical Record–Based Reminder for Cardiovascular Risk Screening in Rheumatoid Arthritis

W. Mowrey, A. Akenroye, A. Kumthekar, 2016, Arthritis care & research.

Prescribing Patterns of Hydroxychloroquine and Glucocorticoids Among Lupus Patients After New‐Onset End‐Stage Renal Disease

Mimi Kim, W. Mowrey, K. Costenbader, 2021, Arthritis care & research.

The complex associations between obstructive sleep apnea and auto-immune disorders: A review.

Steven Y. Park, A. Broder, Mayand Vakil, 2018, Medical hypotheses.

Brief Report: Tubulointerstitial Damage in Lupus Nephritis: A Comparison of the Factors Associated With Tubulointerstitial Inflammation and Renal Scarring

C. Putterman, J. Buyon, B. Goilav, 2018, Arthritis & rheumatology.

Commentary on “The Risky Business of Studying Prognosis”

C. Putterman, A. Broder, 2013, The Journal of Rheumatology.

Association of Medication Access Difficulty and COVID‐19–Related Distress With Disease Flares in Rheumatology Patients During the COVID‐19 Pandemic

T. Rubinstein, L. Bauman, V. Gabbay, 2020, Arthritis care & research.

THU0276 HIGH HYDROXYCHLOROQUINE EXPOSURE IS ASSOCIATED WITH ABNORMAL STRAIN IMAGING IN LUPUS PATIENTS WITH END-STAGE RENAL DISEASE

A. Broder, A. Jimenez, M. Guerrero, 2020, Annals of the Rheumatic Diseases.

Improving Outcomes in Patients with Lupus and End‐Stage Renal Disease

C. Putterman, J. Neugarten, A. Broder, 2013, Seminars in dialysis.

Association of Hydroxychloroquine Dose With Adverse Cardiac Events in Patients With Systemic Lupus Erythematosus

W. Mowrey, D. Horton, M. Salgado Guerrero, 2022, Arthritis care & research.

Commentary on “The Risky Business of Studying Prognosis”

C. Putterman, B. Feldman, L. Lim, 2013, The Journal of Rheumatology.

Hydroxychloroquine Use Is Associated with Lower Odds of Persistently Positive Antiphospholipid Antibodies and/or Lupus Anticoagulant in Systemic Lupus Erythematosus

C. Putterman, A. Broder, 2013, The Journal of Rheumatology.